Investview, Inc.
Investview, Inc. Fundamental Analysis
Investview, Inc. (INVUP) shows weak financial fundamentals with a PE ratio of -33815.11, profit margin of -3.21%, and ROE of -7.73%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 22.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze INVUP's fundamental strength across five key dimensions:
Efficiency Score
WeakINVUP struggles to generate sufficient returns from assets.
Valuation Score
ModerateINVUP shows balanced valuation metrics.
Growth Score
WeakINVUP faces weak or negative growth trends.
Financial Health Score
ExcellentINVUP maintains a strong and stable balance sheet.
Profitability Score
WeakINVUP struggles to sustain strong margins.
Key Financial Metrics
Is INVUP Expensive or Cheap?
P/E Ratio
INVUP trades at -33815.11 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, INVUP's PEG of 405.78 indicates potential overvaluation.
Price to Book
The market values Investview, Inc. at 2673.60 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 39705.89 times EBITDA. This signals the market has high growth expectations.
How Well Does INVUP Make Money?
Net Profit Margin
For every $100 in sales, Investview, Inc. keeps $-3.21 as profit after all expenses.
Operating Margin
Core operations generate -3.47 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-7.73 in profit for every $100 of shareholder equity.
ROA
Investview, Inc. generates $-4.79 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Investview, Inc. generates limited operating cash flow of $-2.13M, signaling weaker underlying cash strength.
Free Cash Flow
Investview, Inc. generates weak or negative free cash flow of $-3.10M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.00 in free cash annually.
FCF Yield
INVUP converts -0.01% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-33815.11
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
405.78
vs 25 benchmark
P/B Ratio
Price to book value ratio
2673.60
vs 25 benchmark
P/S Ratio
Price to sales ratio
1090.91
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.22
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.44
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.08
vs 25 benchmark
ROA
Return on assets percentage
-0.05
vs 25 benchmark
ROCE
Return on capital employed
-0.08
vs 25 benchmark
How INVUP Stacks Against Its Sector Peers
| Metric | INVUP Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -33815.11 | 35.87 | Better (Cheaper) |
| ROE | -7.73% | 1175.00% | Weak |
| Net Margin | -3.21% | -136937.00% (disorted) | Weak |
| Debt/Equity | 0.22 | 0.45 | Strong (Low Leverage) |
| Current Ratio | 2.44 | 4.81 | Strong Liquidity |
| ROA | -4.79% | -312685.00% (disorted) | Weak |
INVUP outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Investview, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Growth, Innovation, High Beta
EPS CAGR
N/A
Industry Style: Growth, Innovation, High Beta
FCF CAGR
N/A
Industry Style: Growth, Innovation, High Beta